.png){kind=small}
Investors
ANVS is an innovative company dedicated to advancing the treatment of neurodegenerative diseases by developing groundbreaking therapies that address Alzheimer's, Parkinson's, and other related disorders, aiming to improve patient outcomes and quality of life.
.svg){kind=icon}
.svg){kind=icon}
.svg){kind=icon}
.svg){kind=icon}
.png){kind=icon}
7M
Americans living with alzheimer's disease
14M
will be Diagnosed with Alzheimer's by 2060
1M
Americans Diagnosed with Parkinson's Disease
1.2M
will be diagnosed with Parkinson's by 2030
Stay Updated with Annovis Bio, Inc.
(NYSE: ANVS)
Join the Annovis Bio Newsletter to receive the latest updates on our groundbreaking research and developments in neurodegenerative diseases like Alzheimer's and Parkinson's
.svg)
.svg)
.svg)
.svg)
